PHI 27 (human) trifluoroacetate is a peptide containing a blend of polar, aromatic, and basic residues that contribute to extended conformational variability. Researchers employ it to explore receptor-contact motifs, helical propensity, and solvent-driven folding. The TFA form enhances solubility and purification robustness. Its composition supports thorough structural studies.
CAT No: R2207
CAS No:2828433-29-8
Synonyms/Alias:PHI 27 (human) trifluoroacetate;EX-A7137;2828433-29-8;
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.